BioSpace News Archive

Chronic Myeloid Leukemia is a cancer that starts in certain blood-forming cells of the bone marrow.

Strata Oncology, Inc . a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced expansion of its clinical collaboration with Pfizer (NYSE: PFE) in the Strata Precision Indications for Approved THerapies (Strata PATHTM) trial.

NanoSpot.ai, producer of digital agglutination-based antibody tests, announced today that it has entered into a commercial and distribution agreement with Opto, an Athroa company and pioneer provider of connected diagnostics.

AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today that the US Patent and Trademark Office has issued a new patent, No. 11,441,191, further strengthening the company’s foundation of intellectual property for its novel StemPrintER test.

Sermonix Pharmaceuticals Inc. today announced results of its signal-seeking Evaluation of Lasofoxifene in ESR1 Mutations (ELAINE 1) Phase 2 study.

EDGC, a company specializing in genomic analysis and precision medicine, announced on the 13th that Sam Martin has been hired as the Vice President of Overseas Business Development.

Innovative Health Diagnostics, a CLIA- and FDA-certified lab that empowers every person by providing access to accurate, clinical testing when and where it matters most, announced that it now offers two at-home diagnostic tests for public purchase online.

Propanc Biopharma, Inc., a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced a shareholder update including recent developments and forecast for the remainder of 2022 and 2023, as the Company prepares to file a 10K annual report which is due on September 30.

Nymox Pharmaceutical Corporation is pleased to provide a current update on business developments.

RapidPulse, Inc., a privately-held medical device company developing a novel aspiration system to treat ischemic stroke, today announced that it has raised an additional $10.5 million, bringing its cumulative financing to over $25 million.